140 related articles for article (PubMed ID: 28888996)
1. Mutations of RNA splicing factors in hematological malignancies.
Shukla GC; Singh J
Cancer Lett; 2017 Nov; 409():1-8. PubMed ID: 28888996
[TBL] [Abstract][Full Text] [Related]
2. Splicing Factor Mutations in Cancer.
Bejar R
Adv Exp Med Biol; 2016; 907():215-28. PubMed ID: 27256388
[TBL] [Abstract][Full Text] [Related]
3. [RNA splicing dysregulation in hematological malignancies].
Yoshida M; Yamauchi H; Sakumoto M; Yoshimi A
Rinsho Ketsueki; 2023; 64(7):646-653. PubMed ID: 37544725
[TBL] [Abstract][Full Text] [Related]
4. Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms.
Brierley CK; Steensma DP
Curr Hematol Malig Rep; 2016 Dec; 11(6):408-415. PubMed ID: 27492253
[TBL] [Abstract][Full Text] [Related]
5. Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors.
Scott LM; Rebel VI
J Natl Cancer Inst; 2013 Oct; 105(20):1540-9. PubMed ID: 24052622
[TBL] [Abstract][Full Text] [Related]
6. Splicing factor gene mutations in hematologic malignancies.
Saez B; Walter MJ; Graubert TA
Blood; 2017 Mar; 129(10):1260-1269. PubMed ID: 27940478
[TBL] [Abstract][Full Text] [Related]
7. [Hematological malignancies driven by aberrant splicing].
Zang W; Saika W; Aoyama Y; Inoue D
Rinsho Ketsueki; 2023; 64(9):875-883. PubMed ID: 37793861
[TBL] [Abstract][Full Text] [Related]
8. RNA-binding protein (RBFOX1) inherited polymorphism rs8051518 is not associated with splice factor mutations in myelodysplastic syndromes and myeloproliferative neoplasms.
Faisal M; Büsche G; Schlue J; Kreipe H; Lehmann U; Bartels S
Ann Hematol; 2019 May; 98(5):1297-1299. PubMed ID: 30159600
[No Abstract] [Full Text] [Related]
9. U2AF1 mutations alter splice site recognition in hematological malignancies.
Ilagan JO; Ramakrishnan A; Hayes B; Murphy ME; Zebari AS; Bradley P; Bradley RK
Genome Res; 2015 Jan; 25(1):14-26. PubMed ID: 25267526
[TBL] [Abstract][Full Text] [Related]
10. Modeling human RNA spliceosome mutations in the mouse: not all mice were created equal.
Xu JJ; Smeets MF; Tan SY; Wall M; Purton LE; Walkley CR
Exp Hematol; 2019 Feb; 70():10-23. PubMed ID: 30408513
[TBL] [Abstract][Full Text] [Related]
11. Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
Pellagatti A; Boultwood J
Adv Biol Regul; 2017 Jan; 63():59-70. PubMed ID: 27639445
[TBL] [Abstract][Full Text] [Related]
12. The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
Boultwood J; Dolatshad H; Varanasi SS; Yip BH; Pellagatti A
Adv Biol Regul; 2014 Jan; 54():153-61. PubMed ID: 24080589
[TBL] [Abstract][Full Text] [Related]
13. Splice factor mutations and alternative splicing as drivers of hematopoietic malignancy.
Hahn CN; Venugopal P; Scott HS; Hiwase DK
Immunol Rev; 2015 Jan; 263(1):257-78. PubMed ID: 25510282
[TBL] [Abstract][Full Text] [Related]
14. RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies.
Li Z; He Z; Wang J; Kong G
J Leukoc Biol; 2023 Feb; 113(2):149-163. PubMed ID: 36822179
[TBL] [Abstract][Full Text] [Related]
15. Insights from structures of cancer-relevant pre-mRNA splicing factors.
Kielkopf CL
Curr Opin Genet Dev; 2018 Feb; 48():57-66. PubMed ID: 29128695
[TBL] [Abstract][Full Text] [Related]
16. Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome.
Madan V; Kanojia D; Li J; Okamoto R; Sato-Otsubo A; Kohlmann A; Sanada M; Grossmann V; Sundaresan J; Shiraishi Y; Miyano S; Thol F; Ganser A; Yang H; Haferlach T; Ogawa S; Koeffler HP
Nat Commun; 2015 Jan; 6():6042. PubMed ID: 25586593
[TBL] [Abstract][Full Text] [Related]
17. Splicing factor mutations in hematologic malignancies.
Chen S; Benbarche S; Abdel-Wahab O
Blood; 2021 Aug; 138(8):599-612. PubMed ID: 34157091
[TBL] [Abstract][Full Text] [Related]
18. Alternative splicing of U12-dependent introns in vivo responds to purine-rich enhancers.
Dietrich RC; Shukla GC; Fuller JD; Padgett RA
RNA; 2001 Oct; 7(10):1378-88. PubMed ID: 11680842
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of the U12-dependent branch site consensus sequence.
Brock JE; Dietrich RC; Padgett RA
RNA; 2008 Nov; 14(11):2430-9. PubMed ID: 18824513
[TBL] [Abstract][Full Text] [Related]
20. Biological relevance of alternative splicing in hematologic malignancies.
Szelest M; Giannopoulos K
Mol Med; 2024 May; 30(1):62. PubMed ID: 38760666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
